Signaling Pathways
-
B2298 Plinabulin (NPI-2358)Target: Vascular Disrupting Agents (VDA)Summary: vascular disrupting agent
-
B1089 CMX001Summary: Broad spectrum antiviral drug
-
B2235 ClozapineTarget: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 ReceptorsSummary: 5-HT receptor antagonist
-
B2240 OlanzapineTarget: 5-HT2 Receptors|D2 ReceptorsSummary: Antagonist of 5-HT2A and dopamine D2 receptors
-
B2232 AripiprazoleTarget: 5-HT1 ReceptorsSummary: 5-HT receptor partial agonist
-
B1926 Dexamethasone acetateTarget: Glucocorticoid Receptors|interleukin receptorSummary: IL Receptor modulator
-
B1375 Dehydroepiandrosterone (DHEA)Summary: Endogenous steroid hormone
-
B1407 Dabrafenib (GSK2118436)3 CitationTarget: RafSummary: Inhibitor of BRAF(V600) mutants
-
B1267 RefametinibTarget: MEKSummary: MEK 1/ MEK 2 inhibitor
-
B1114 T 705Target: RNA PolymerasesSummary: Potent and selective RNA-dependent RNA polymerase inhibitor